货号：UP621217498
| 产品信息 | |
| 产品名称： | MF498 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 915191-42-3 |
| 分子式： | C32H33N3O7S |
| 分子量： | 603.69 |
| MDL NO： | MFCD17166964 |
| 标准纯度： | 98+% (UP621217498) |
| 沸点： | - |
| 储存： | (UP621217498) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Bortezomib
UP959825699179324-69-7
LECIRELIN
UP65359667161012-19-9
4,4,4,4-(Porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)
UP991351831914609-54-2
YM-155 hydrochloride
UP263151238355406-09-6
Nafarelin
UP77098863676932-56-4
Pifithrin-α hydrobromide
UP58121045763208-82-2
Kevetrin hydrochloride
UP52273339366592-89-0
Resiquimod
UP458050387144875-48-9
Necrostatin 1
UP4191557134311-88-0
Boric anhydride
UP34112545591303-86-2
GSK481
UP3600794531622849-58-4
Elagolix
UP789444331834153-87-6
6-Cyano-9-(diethylamino)-5H-benzo[a]phenoxazin-5-one
UP7493105643128119-95-9
Triptorelin
UP75587421057773-63-4
TC-DAPK 6
UP669043601315694-89-4
Neratinib Maleate
UP200720262915942-22-2
Pomalidomide
UP70220021219171-19-8
Oprozomib
UP242482345935888-69-0
LJH685
UP7665361461627710-50-2
MK-3697
UP1412659781224846-01-8
Mutated EGFR-IN-1
UP1200422071421372-66-8
AKT inhibitor VIII
UP998464122612847-09-3
Cloprostenol sodium salt
UP943997077555028-72-3
Dehydroglyasperin C
UP549406836199331-35-6
Lenalidomide hydrochloride
UP2933778241243329-97-6
BIX-02565
UP4639477991311367-27-7
BI-D1870
UP683157370501437-28-1
LY2584702
UP1870046981082949-67-4
Trimebutine
UP94753881139133-31-8
LY2584702 Hydrochloride
UP1960674401082948-81-9
AC480
UP309988617714971-09-2
(2S,5R,6R)-6-(3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]
UP251101961847-24-1
LJI308
UP2304532831627709-94-7
Carfilzomib
UP896392163868540-17-4
SL0101
UP72975987777307-50-7
FMK
UP264278495821794-92-7
BMS-582949 hydrochloride
UP489685950912806-16-7
PF-4708671
UP6266908551255517-76-0
GNF-6702
UP1643646281799329-72-8
TRAP-6
UP419858883141136-83-6
CMK
UP846339860821794-90-5
Ixazomib citrate
UP5222289451239908-20-3
Kasugamycin
UP9371143726980-18-3
Troglitazone
UP18837082797322-87-7
4-Amino-2,2,6,6-tetramethylpiperidino-1-oxyl
UP73238154314691-88-4
Ixazomib
UP4269519471072833-77-2
ONX-0914
UP137683927960374-59-8
ELR510444
UP9545513021233948-35-0
Vicriviroc maleate
UP403516778599179-03-0
MG-132
UP890361061133407-82-6
Afuresertib hydrochloride
UP2644866581047645-82-8
PI-1840
UP5770548671401223-22-0
1-Ethyl-2-(3-(1-ethyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide
UP452601431614696-39-0
Exendin-4
UP925639199141758-74-9
Futoenone
UP79077632519913-01-0
N,N'-Bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylic Diimide
UP404621138882953-57-9
Capzimin
UP6273444522084868-04-0
LY2584702 Tosylate
UP1382298701082949-68-5
Epoxomicin
UP820527281134381-21-8
Verdinexor
UP4794957021392136-43-4
Etelcalcetide
UP1781276241262780-97-1
Lysipressin
UP12939204050-57-7
SB-225002
UP931912876182498-32-4
Celastrol
UP96542150434157-83-0
VR23
UP7993412731624602-30-7
Dalbergioidin
UP39250900730368-42-4
MBX-2982
UP6022852021037792-44-1
RAF265
UP661067803927880-90-8
MI 2 MALT1 inhibitor
UP2568173211047953-91-2
CJ-42794
UP376670283847728-01-2
Iloprost
UP68412330178919-13-8
NS-304
UP627761985475086-01-2
AH 6809
UP94335491333458-93-4
GW627368
UP750622116439288-66-1
Prostaglandin E2
UP294583883363-24-6
Ethamsylate
UP4746295382624-44-4
ONO-AE3-208
UP355644302402473-54-5
MF498
UP621217498915191-42-3